CHM chimeric therapeutics limited

Ann: AML patient achieves Complete Response in CHM CORE-NK trial, page-8

  1. 56 Posts.
    lightbulb Created with Sketch. 17
    I assume there may be un upcoming webinar and I think it would be something to ask management about including how the extra capital from the raise will help expedite trials. The platform theyre using is new so it is in everyone's best interest to speed things up for patients and to reduce the risk of late movers coming over the top of CHM.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.747M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.858K 619.3K

Buyers (Bids)

No. Vol. Price($)
66 58647032 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 107164382 32
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.